Alignment-guided mutagenesis was used to create an inactive, but toxic, aminoacyl-tRNA synthetase. An
tant enzyme in a cell with a wild-type ileS chromosomal allele resulted in cell death. Introduction of a second K732T substitution previously shown to weaken tRNA binding gives an inactive D96A/K732T double mutant. Expression of the double mutant is not lethal to E. coli. D96A but not the double mutant significantly inhibited in vitro charging of isoleucine tRNA by the wild-type enzyme. The results suggest a dominant tRNA binding-dependent arrest of cel growth caused by a reduction in the pool of a specific tRNA. Specific tRNA binding drugs may have therapeutic applications for treatment of microbial pathogens.
The 20 Escherichia coli aminoacyl-tRNA synthetases are essential enzymes that catalyze the esterification of an amino acid to its cognate tRNA. Based on conserved sequence and structural motifs, the 20 synthetases are divided into two classes of 10 enzymes each (1-4). Class I enzymes have a well-conserved N-terminal nucleotide binding (or Rossmann) fold responsible for amino acid binding, aminoacyl-adenylate formation, and tRNA acceptor helix docking joined to a less-conserved C-terminal domain responsible for tRNA anticodon loop binding (5) (6) (7) (8) (9) . Based on additional sequence similarities, a subgroup containing the five most closely related class I synthetases has been defined and includes the synthetases specific for cysteine, isoleucine, leucine, methionine, and valine (10) .
The N-and C-terminal domains of this subgroup of synthetases appear to act independently. Mutations in the N-terminal domain, which virtually abolish amino acid binding or aminoacyl-adenylate formation, do not affect tRNA binding activity by the C-terminal domain (11, 12) . Similarly, C-terminal mutations affecting tRNA binding have little effect on amino acid binding, aminoacyl-adenylate formation, or aminoacylation ofa microhelix based on the tRNA acceptor stem (5, 13, 14) . Further evidence for the modularity of structure of members of this subgroup of class I synthetases comes from demonstrations of noncovalent assembly of active enzymes from discrete pieces (6, 7, 15) .
Because aminoacyl-tRNA synthetases and tRNAs are essential components needed to establish the genetic code relationship between amino acids and trinucleotides, any alteration in the efficiency or accuracy of the aminoacylation reactions in vivo is expected to lead to cell toxicity. Previous investigations demonstrated toxicity from apparent misacylation reactions of a heterologous (non-E. coli) tyrosine
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tRNA synthetase expressed in E. coli (16, 17) . In addition, expression in E. coli of a tRNA-specificity mutant of E. coli glutaminyl-tRNA synthetase slows cell growth, presumably because of misacylation reactions (18) . We sought an alternative way to achieve tRNA synthetase-induced cell death and, in particular, wanted to exploit recent evidence that mutations that affect one interaction or activity (e.g., binding to the anticodon) need not affect another function (e.g., amino acid activation and acceptor helix interactions). We imagined that an inactive enzyme that retained its tRNA binding activity would, in sufficient concentrations, sequester much of its cognate tRNA and thereby arrest protein synthesis by effectively starving cells for a specific charged tRNA species. Because specific tRNAs are not present in substantially greater concentrations than their cognate synthetases (19), the possibility of a tRNA binding-dependent arrest of cell growth seemed plausible. Moreover, the recent reports of single point mutations or deletions that selectively inactivate either tRNA binding or amino acid activation (5, (11) (12) (13) (14) suggested that single and double mutants might be constructed to investigate and establish this possibility. for site-directed mutagenesis. The phagemid allows for inducible expression of IleRS from the lac promoter and contains the (-lactamase gene conferring ampicillin resistance.
MATERIALS AND METHODS
Site-Directed Mutagenesis and Complementation Assays. Single-stranded DNA was isolated from the pKS21 phagemid and used as a template for introduction of the Asp-96 -* Ala (D96A) mutation via the Amersham oligonucleotide mutagenesis system (Amersham). Resulting phagemids were sequenced and those containing only the desired mutation were selected. A second K732T mutation was introduced into the mutant D96A plasmid by subcloning a BsiWI/Eco47IhI fragment containing K732T from pAS205 (5) into the pKS21 phagemid encoding the D96A mutant. The wild-type, D96A mutant, and D96A/K732T double-mutant pKS21 phagemids were transformed into the tester strain IQ844/pRMS711 and tested for growth at the permissive (30°C) and nonpermissive (42°C) temperatures.
In Vivo Expression Experiments. Phagemids were transformed into MV1184 cells and overnight cultures were grown from single colonies and then diluted 1:150 into LB/ ampicillin. Two separate cultures were grown at 37°C for each IleRS mutant. One of the cultures was induced with 1 mM IPTG (Sigma) at OD6w00 0.250. An equal volume of water was added to the other. Growth was monitored for up to 11 h by measuring cell densities by OD600 on a Beckman DU-64 spectrophotometer.
Western Blotting. Small scale samples were removed from each culture at the end of the time course. Cell densities were normalized and cells were lysed by boiling in gel loading buffer. Extracts were fractionated by SDS/PAGE on a 7% gel. Proteins were transferred onto an Immobilon-P PVDF membrane using a Milliblot semidry blotting apparatus (Millipore). The blots were blocked in milk, incubated with rabbit anti-E. coli IleRS antiserum (21), and then treated with donkey anti-rabbit IgG linked to horseradish peroxidase (Amersham). The blots were developed using the ECL chemiluminescent system (Amersham).
Enzyme Purification and Enzyme Assays. One-liter cultures of MV1184 cells harboring the pKS21 phagemid encoding wild-type IleRS were induced during logarithmic phase and grown to saturation. Protein purification was performed as described by Shepard et al. (5) . The inactive IleRS proteins encoded by D96A and D96A/K732T mutant pKS21 phagemids were purified in the same manner but from 1-liter cultures of strain MI1. In these cultures, plasmid-encoded synthetase was overexpressed >10-fold in relation to chromosomally encoded enzymes (data not shown). Enzyme concentrations were determined by Bradford analysis (BioRad) with bovine serum albumin as a standard or by active site titration (22).
Standard aminoacylation reactions were performed as described by Shepard et al. (5) but at ambient temperature using 1 nM enzyme and 5 ,uM purified tRNAIle (Subriden RNA). The aminoacylation reaction with various amounts of mutant inhibitory IleRS was performed similarly with 2 nM wild-type IleRS, 100 nM purified tRNAIle, and 0-1 uM mutant IleRS.
The reaction mixture (without wild-type and mutant IleRS) was preincubated at ambient temperature. Mutant proteins were added and the sample was mixed. Wild-type protein was added soon after, followed by further mixing. It was noticed that if mutant proteins were allowed to preincubate in the reaction mixture for longer times (5-10 min), then their inhibitory effects increased. For results reported here, we used short (<20 sec) preincubation times. To detect small quantities of charged tRNA, the specific activity of [3H]isoleucine was increased to 1670 cpm/pmol in these experiments. The filter binding reaction mixture (100 ,ul) contained 20 mM Hepes (pH 7.5), 0.1 mM EDTA, 0.15 M NH4Cl, 100 pg of bovine serum albumin per ml, 4mM MgCl2, and 25 nM IleRS. After preincubation at ambient temperature, [3H]isoleucinetRNAIle was added at 25-5000 nM. The entire reaction mixture was filtered through a 24-mm nitrocellulose disk (Schleicher & Schuell) prewashed in ice-cold 20mM Tris HCl (pH 7.5) and 150 mM KCI. After three 1-ml washes of the same solution, the fllters were dried and assayed in Betafluor (National Diagnostics, Manville, NJ). Data were subjected to Scatchard analysis (25).
RESULTS
Alignment-Guided Inactivation by Mutagenesis of IleRS. Fig. 1 shows the predicted secondary structure of the N-terminal domain of E. coli IleRS based on sequence alignments with methionyl-tRNA synthetase (MetRS), for which a threedimensional structure has been solved (8, 34). The structure is composed of alternating j-strands and a-helices arranged in a Rossmann nucleotide binding fold. A large and variable insertion designated CP1 (connective polypeptide 1) occurs between the third 3-strand (13c) and a-helix (ac) and a second insertion CP2 occurs between the fourth (-strand ((8D) and a-helix (aD) . Also shown are aligned sequences of the known synthetases specific for isoleucine and methionine. The high degree of N-terminal sequence homology between the subgroup of class I synthetases has made possible alignments of conserved and potentially critical residues (5, 6, 10, 11).
A D52A mutation in the N-terminal domain of E. coli MetRS results in a stable protein characterized by a greatly reduced kcat for aminoacyl-adenylate formation (11). To produce an IleRS devoid of aminoacylation activity, we introduced a D96A mutation into the aligned nucleotide binding fold at the analogous location of IleRS. The aspartic acid residue targeted for mutagenesis is conserved in all known IleRSs and MetRSs and in all but one (Neurospora crassa leucyl-tRNA synthetase) of the known subgroup class I synthetases (6, 10).
The D96A mutation resulted in stably produced protein devoid of activity as measured by its inability to complement the ileS null strain IQ844/pRMS711. Mutant or wild-type phagemid was introduced into the tester strain by electroporation. Transformants were plated directly at the permissive (30°C) or nonpermissive (42°C) temperature and scored for growth. Mutant phagemid produced zero transformants at 42°C. Wild-type phagemid produced equal numbers of transformants at nonpermissive and permissive temperatures. Loss of pRMS711 at the nonpermissive temperature was confirmed by assaying for chloramphenicol sensitivity (loss of the drug-resistance marker carried by pRMS711) in complementing phagemid transformants.
The mutant's inactivity supports the sequence alignment and the close functional relationship between the N-terminal domains of this subgroup of class I synthetases. We would predict that mutagenesis of Asp-85 (Saccharomyces cerevisiae), Asp-87 (Methanobacterium thermoautrophicum), and Asp-91 (Tetrahymena thermophila) of IleRS, and of Asp-40 (Thermus thermophilus), Asp-60 (S. cerevisiae mitochondrial), Asp-244 (S. cerevisiae cytoplasmic), and Asp-51 (Bacillus stearothermophilus) ofMetRS in published alignments (6,11) would lead to similarly inactive IleRSs and MetRSs. Analogous residues can be identified in most of the other members (leucine, valine, and cysteine) of the class I subgroup. However, because of the lack of comparable sequence sim- (Fig. 2 A and B) .
The dominant lethality of the D96A mutant is most likely related to its ability to bind tRNAIle. Because it is unable to catalyze aminoacylation, the mutant could sequester tRNA from the endogenous wild-type synthetase and the cell's protein synthesis machinery. Further experiments tested the hypothesis that tRNAIle is the in vivo target responsible for the toxicity of D96A IleRS.
Suppression of Dominant Lethality of D96A IleRS by a Second Distal Mutation. A K732T mutation was placed in the C-terminal domain of the D96A mutant enzyme with the purpose of disrupting the enzyme's ability to bind tRNAIIe. This mutation increases the Km for tRNAIIe in the aminoacylation reaction by 225-fold (5). [The identification of Lys-732 as a residue involved in tRNA binding was also made possible by sequence alignments between the C-terminal domain of isoleucyl-and methionyl-specific synthetases (5).] Lys-732 is conserved as a basic residue in all published IleRS sequences (Fig. 1) . The resulting double-mutant D96A/K732T IleRS accumulated in vivo but was unable to complement the IQ844/pRMS711 null strain.
Introduction of the C-terminal K732T mutation into the D96A mutant IleRS relieved almost all of the inhibitory effects of mutant IleRS expression on the growth of MV1184 cells (Fig. 2C ). Western blot analysis (Fig. 3) showed that the D96A and D96A/K732T mutant proteins are expressed at approximately equal levels. Thus, disrupting the D96A mutant enzyme's capacity to bind tRNAne relieved its dominant in vivo toxicity.
Inhibition of in Vitro Aminoacylation by D96A but Not D96A/K732T IleRS. The pKS21-encoded D96A and D96A/ K732T mutant enzymes were expressed and purified from MIl cells, which contain a mutant chromosomal ileS allele (see Materials and Methods). The MIl-encoded IleRS has a high Km for isoleucine (>100 ,uM) and is able to maintain cell viability in vivo only when cell media are supplemented with isoleucine (20). The activity of the MIl mutant enzyme is not Experiments were conducted as described in Materials and Methods. detectable under normal in vitro assay conditions which use 20 ,uM isoleucine. These circumstances allow for direct biochemical analysis of overproduced mutant proteins purified from this strain. Fig. 4 shows that, under the conditions ofthe assay, no activity could be detected for either the D96A or the Mll strain's mutant enzyme. Additional experiments showed that the D96A mutant had a severely reduced kcat for aminoacyl-adenylate formation much like the mutant methionyl-synthetase after which it was designed (data not shown).
A nitrocellulose filter binding assay was used to determine the apparent dissociation constant of the IleRSIleAtRNAIle complex at pH 7.5. The aminoacylated form of tRNAIle was used for these experiments because it is the predominant form of tRNA in vivo (35) and the amino acid provided a convenient radiolabel. These experiments indicated similar dissociation constants of 0.33 and 0.48 ,uM for the wild-type and D96A mutant enzyme-tRNA complexes, respectively. The double-mutant D96A/K732T IleRS had a Kd for complex dissociation too high (>3 uM) to be measured by this assay. Using these purified mutant IleRS proteins, we set up in vitro charging assays designed to mimic the in vivo expression studies. The aminoacylation activity of catalytic amounts of wild-type enzyme was measured in the presence of substrate levels of D96A or D96A/K732T protein. A prediction ofthe tRNA sequestering hypothesis is that, as the concentration of the D96A mutant protein is increased in concentration through its Kd for tRNA, the available free tRNAIe is decreased, leading to inhibition of charging. The D96A mutant, but not the D96A/K732T double mutant, significantly inhibited aminoacylation over the concentration range investigated (Fig. 5) .
DISCUSSION
These results demonstrate tRNA synthetase-induced toxicity ascribable to a reduction in available levels of an aminoacylated tRNA isoacceptor. Inokuchi et al. (18) have reported slower growth rates of E. coli expressing a mutant of glutaminyl-tRNA synthetase. The mutant had a relaxed specificity for tRNA in vivo and in vitro. While growth rates were not detailed, the authors ascribed the slower bacterial growth rate to in vivo tRNA mischarging. The mutant synthetase retained its ability to aminoacylate tRNAG0n.
The results reported here demonstrate a dominant lethal phenotype as a result of induction of a mutant tRNA synthetase in its homologous organism. Bedouelle et al. (16) and Vidal-Cros and Bedouelle (17) have documented dominant lethality caused by overexpression of heterologous wild-type and mutant B. stearothermophilus tRNA synthetases in E. coli. In these cases the authors seem to favor tRNA mischarging as the likely mechanism of lethality.
The results of in vivo expression of and in vitro inhibition by the D96A and D96A/K732T mutant proteins strongly suggest that a tRNA binding-dependent activity is responsi- 
